Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143460 |
| CAS No | NA |
| Mol.F. | C13H13N3O4 |
| Mol.Wt. | 275.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143461 |
| CAS No | NA |
| Mol.F. | C13H10ClN3O2 |
| Mol.Wt. | 275.69 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143462 |
| CAS No | NA |
| Mol.F. | C25H38N4O9 |
| Mol.Wt. | 538.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143463 |
| CAS No | NA |
| Mol.F. | C25H37N5O10 |
| Mol.Wt. | 567.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143464 |
| CAS No | NA |
| Mol.F. | C22H34N4O9 |
| Mol.Wt. | 498 .5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143465 |
| CAS No | NA |
| Mol.F. | C19H28N4O7 |
| Mol.Wt. | 424.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143466 |
| CAS No | 1026879-47-9 |
| Mol.F. | C27H33N3O8 |
| Mol.Wt. | 527.6 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143467 |
| CAS No | NA |
| Mol.F. | C7H6BrN5O3 |
| Mol.Wt. | 288.06 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143468 |
| CAS No | NA |
| Mol.F. | C6H4BrN5O3 |
| Mol.Wt. | 274.03 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143469 |
| CAS No | NA |
| Mol.F. | C4H10N2O2 |
| Mol.Wt. | 118.14 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143470 |
| CAS No | 943-41-9 |
| Mol.F. | C7H7N3O3 |
| Mol.Wt. | 181.15 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143471 |
| CAS No | NA |
| Mol.F. | C19H28N4O7 |
| Mol.Wt. | 424.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143472 |
| CAS No | NA |
| Mol.F. | C7H12N4O3 |
| Mol.Wt. | 200.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143473 |
| CAS No | NA |
| Mol.F. | C25H36N4O9 |
| Mol.Wt. | 536.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143474 |
| CAS No | NA |
| Mol.F. | C20H31N3O7 |
| Mol.Wt. | 425.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143475 |
| CAS No | NA |
| Mol.F. | C13H17N5O7S |
| Mol.Wt. | 387.37g/mole |
| INV STATUS | CUSTOM SYNTHESIS |